17Jul 2021
The efficacy and safety of ocriplasmin for patients with vitreous macular traction

The efficacy and safety of ocriplasmin for patients with vitreous macular traction

To estimate the efficacy and safety of ocriplasmin for patients with vitreous macular traction (VMT). The PubMed, EMBASE and Ovid were searched up to May 2020 to identify related studies. Statistical analysis was conducted by R software version 3.6.3. Results in proportion with 95% confidence interval (CI) were calculated by means of Freeman–Tukey variant of arcsine square transformation. The pooling results indicated the overall complete release rate was 50% (95% CI [45%–54%]). For VMT patients younger than 65 years old...

  • #ophthalmology

Like

Save

Share